Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 16, 2003

View Archived Issues

Microscience collaborates with NMRC to test anthrax vaccine

Long-term safety and efficacy of SPM-927 in epilepsy

Corixa reports development status of two MPL-containing vaccines

deCODE isolates new obesity genes

Topline results from pivotal Metformin GR study

Lexapro as effective as Zoloft in recent study

T-62 enters phase I testing for neuropathic pain

Phase I trial commences for CNTO-95

Avanir and Peregrine execute license agreement for antibody

Praecis collaborates with NCI on PPI-2458

R-112 safe and well tolerated in phase I study

Rifaximin NDA amendment considered complete response

Inhibition of factor 5A1 reduces apoptosis caused by TNF-alpha

Dosing complete in phase I Oxycyte study

Xechem to acquire Ceptor

Phase II trial evaluates RG-1068 for refractory schizophrenia

Fujisawa launches pediatric Protopic in Japan

Good safety profile observed for a West Nile virus vaccine in monkeys

Phase I clinical results reported for MalariVax

Compositions of lafutidine for IBD

Pyrimidine-based compounds that inhibit elastase described by Ono

Sumitomo patents new series of DPP-IV inhibitors

Macrolide antibacterial agents identified at Abbott

BMS prepares new anti-HIV series

Modulators of NK cell activity and their application described in recent patent

ST-1899: pharmacological profile indicates promise in schizophrenia

Antibacterial activity, pharmacokinetics and toxicity of HARP antibacterial compounds

Potential use of AQ-13 for malaria unresponsive to current aminoquinolines

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...